Roivant Sciences (ROIV) insider trading in the last 6 months
3 insiders sold $176M. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Form 4 filings, newest first
Who files at Roivant Sciences
Questions about ROIV's insider trades
Are ROIV insiders buying or selling?
3 insiders sold $176M across 20 filings in the last 6 months. No open-market buys on record. The newest filing: Mayukh Sukhatme, President & CIO, sold $6.4M on Aug 19, 2026.
Who are ROIV's biggest insider sellers?
By the dollars of their sales in the last 6 months: Mayukh Sukhatme (President & CIO), 9 sales; Keith S. Manchester (Director), 6 sales; Daniel Allen Gold (Director), 5 sales.
When did an ROIV insider last buy?
No ROIV insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Mayukh Sukhatme on Aug 19, 2026.
Roivant Sciences's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma.